MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group - Quiz - MDSpire

MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group

  • By

  • Gülin Öz

  • Sirio Cocozza

  • Thiago J. R. Rezende

  • Pierre-Gilles Henry

  • Jennifer Faber

  • Ian H. Harding

  • June 3, 2026

  • 0 min

Share

Original Source(s)

MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group

  • by Gülin Öz, Sirio Cocozza, Thiago J. R. Rezende, Pierre-Gilles Henry, Jennifer Faber, Ian H. Harding

  • June 3, 2026

Related Content

The impact of aging on locomotor recovery in preclinical models of traumatic spinal cord injury: a systematic review

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

Consensus Guidance May Improve Sinonasal Mass Outcomes

Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.